about
Budd-Chiari syndrome: diagnosis with three-dimensional contrast-enhanced magnetic resonance angiography.GLP-1R-targeting magnetic nanoparticles for pancreatic islet imaging.Combined small interfering RNA therapy and in vivo magnetic resonance imaging in islet transplantationCombining miR-10b-Targeted Nanotherapy with Low-Dose Doxorubicin Elicits Durable Regressions of Metastatic Breast Cancer.Combination of active targeting, enzyme-triggered release and fluorescent dye into gold nanoclusters for endomicroscopy-guided photothermal/photodynamic therapy to pancreatic ductal adenocarcinoma.A theranostic small interfering RNA nanoprobe protects pancreatic islet grafts from adoptively transferred immune rejectionImmune rejection after pancreatic islet cell transplantation: in vivo dual contrast-enhanced MR imaging in a mouse model.Predictive imaging of chemotherapeutic response in a transgenic mouse model of pancreatic cancerTherapy targeted to the metastatic niche is effective in a model of stage IV breast cancer.Molecular Imaging of Stem Cell Transplantation for Liver Diseases: Monitoring, Clinical Translation, and Theranostics.Monitoring of Allogeneic Islet Grafts in Nonhuman Primates Using MRI.Molecular Imaging of Stems Cells: In Vivo Tracking and Clinical Translation.In Vivo Magnetic Resonance Imaging of Small Interfering RNA Nanodelivery to Pancreatic Islets.Magnetic particle imaging of islet transplantation in the liver and under the kidney capsule in mouse models.Magnetic resonance imaging of intra-pancreatic ductal nanoparticle delivery to islet cellsNew Strategies and In Vivo Monitoring Methods for Stem Cell-Based Anticancer TherapiesNano-immunoimaginguMUC1-Targeting Magnetic Resonance Imaging of Therapeutic Response in an Orthotropic Mouse Model of Colon CancerMagnetic Particle Imaging: Current Applications in Biomedical ResearchNucleic acid-based theranostics in type 1 diabetes
P50
Q30396920-0BA255CA-3967-418C-9D55-44E00E021556Q30588445-B0F7EA4C-9944-4BDE-8467-F1D03CD83DC3Q34527135-53712DF7-C589-425D-B50D-FCBB46424EFBQ36172660-47A2E68B-5E65-4217-8E04-2836F9DE7F1FQ36393136-556F78F3-733D-4A57-A3DB-46ADF266082BQ36410697-B1E11C04-5C85-4ABE-AF49-872FB12D8ABEQ36628967-995A564F-2475-4C3E-B66F-32439A266EFEQ37047682-C55488B2-4FA3-4ACC-8870-B5EBA36BA812Q37712909-EDBD855E-3EAB-4F29-A738-5DC0E405603DQ38772557-0ED6F039-C6FD-488F-BB04-B635B4A225E4Q41835058-C7D4EEAB-E5BF-4899-8FC7-9CF265CF04DAQ42330288-87745A27-0312-4C0E-8061-BBE5C2409E14Q48643933-F303AD2C-EE04-4C4E-8895-366B8CEB44C9Q52575818-13126A3D-BCAE-4E37-ABA3-76013C8AB656Q58630370-50F5A250-9E33-49A6-8494-18A0BBCF66F1Q90729465-134FA6E3-3CA2-4E75-8F1A-29267D2FB796Q90749438-2452D4F4-FB05-4B5B-9078-F4949290C0BDQ91821260-A03FA0AC-53D6-4EE1-A1A7-27E2E0C549D1Q92099417-F397F9D8-1885-42EA-B378-0DF85CF96834Q93151229-D262ADC2-2338-46B4-BB43-59890438404C
P50
description
onderzoeker
@nl
researcher ORCID: 0000-0001-6712-8939
@en
name
Ping Wang
@ast
Ping Wang
@en
Ping Wang
@es
Ping Wang
@nl
Ping Wang
@sl
type
label
Ping Wang
@ast
Ping Wang
@en
Ping Wang
@es
Ping Wang
@nl
Ping Wang
@sl
prefLabel
Ping Wang
@ast
Ping Wang
@en
Ping Wang
@es
Ping Wang
@nl
Ping Wang
@sl
P106
P1153
55507659600
P31
P496
0000-0001-6712-8939